missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IGF-I/IGF-1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
N.V.
Spezifikation
| Zusammensetzung | Lyophilized from a 0.2μm filtered solution in PBS. |
|---|---|
| Gen-ID (Entrez) | 3479 |
| Molekulargewicht | 7.6 kDa |
| Name | IGF-I/IGF-1 |
| Quelle | E. coli-derived human IGF-I/IGF-1 protein Gly49-Ala118 |
Beschreibung
Measured in a serum-free cell proliferation assay using MCF-7 human breast cancer cells. Karey, K.P. et al. (1988) Cancer Research 48:4083. The ED50 for this effect is 0.3-1.5 ng/mL.Spezifikation
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 7.6 kDa | |
| E. coli-derived human IGF-I/IGF-1 protein Gly49-Ala118 | |
| Unconjugated | |
| >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| 3479 | |
| IGF-I/IGF-1 | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |